bmiMD vs Wholesome Clinic
Fifty states at a fixed rate against seven states with the escalation published.
bmiMD
Editorial
$99/mo
Compounded semaglutide and compounded tirzepatide, both sold as microdose lines and both priced flat across doses. The $99 semaglutide rate is the twelve-month tier; a single month is $129. Each product page strikes a higher figure through and labels it a limited time offer, without dating it.
Pick it for: Buyers outside Wholesome Clinic's seven states, or who want the rate pinned
Wholesome Clinic
Editorial
$109/mo
A self-pay practice that publishes the whole dose ladder rather than an opening figure. Semaglutide runs from $149 injected and $109 oral, tirzepatide from $349 injected and $249 oral, and each opens a three-rung ladder the pages print in full. Seeing the second and third rungs before enrolling is the disclosure; the tirzepatide injection ends $200 above where it starts. Coverage is seven states.
Pick it for: Buyers who would rather see the escalation than be surprised by it
Our verdict
BMIMD states a flat $99 across fifty states; Wholesome Clinic opens at $109 in seven and prints all three rungs of each ladder. One is cheaper to hold, the other is more honest about the climb.
What actually separates them
bmiMD and Wholesome Clinic state different things about published price and where you can use it. Everything else they publish, they publish the same way.
Wholesome Clinic costs $10 more than bmiMD — 10% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,188 at bmiMD against $1,308 at Wholesome Clinic — a difference of $120.
| bmiMD | Wholesome Clinic | |
|---|---|---|
| Published price | $99/mo | $109/mo |
| Where you can use it | 50 states | 7 states |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.